Dexcom's manufacturing facility in Galway, the completion of Hamburg's 18,000 sq m UKE research building and 4basebio's 37,000 sq ft Cambridge laboratory lease.
TPG's €400 million Project Nightingale acquisition, Trinity by Breakthrough's 214,000 sq ft Oxford completion and Syngenta's $130 million BioSTaR facility in Berkshire.